The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder

OBJECTIVE: Vilazodone is a selective serotonin reuptake inhibitor and 5-HT(1A) receptor partial agonist approved for the treatment of major depressive disorder (MDD). This report summarizes the safety and tolerability of vilazodone 40 mg/day during short- and long-term treatment of adult MDD. METHOD...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Psychopharmacol Bull
Autores principales: Liebowitz, Michael, Croft, Harry A., Kajdasz, Daniel K., Whalen, Heidi, Gallipoli, Susan, Athanasiou, Maria, Reed, Carol R.
Formato: Artigo
Lenguaje:Inglês
Publicado: MedWorks Media Global 2011
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044546/
https://ncbi.nlm.nih.gov/pubmed/27738360
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares